Indian Journal of Science and Technology

Open Access Open Access  Restricted Access Subscription Access

Understanding of MRHU-plasmids, Bacterial Adherence and Biomaterial in Clinical Application


Affiliations
1 Department of Chemical Engineering Indian Instiute of Technology, Kharagpur-721302, W.Bengal, India
 

Bacterial adherence has been recently reviewed by plasmid genetic properties of MRHU (D-mannose resistant haemagglutination of human erythrocytes) and change of surface antigens, fimbriae=pili, as an elongated protein appendages to facilitate transport of haemagglutine from cell to bacterial membrane, to lipopolysaccaride (LPS) and to hosts. The fimbriae=pili as expanding elongated protein appendages, have been recently characterised as BNT (Bionanotube) or as ionic channels. The transport of secondary metabolites, haemagglutinine passing through membrane to the external surface, may cause MRHU the colonizations. The mechanisms of MRHU (agglutinating RBC) and their pathogenic activities have been characterised against immune responses (IR) in Balb/C mice. Both the cells and fimbriae showed similar results at different time span. Based on observations, the author designed the concept of one 'Bio-material' to be used for continuous vaccinations and for slow IR, which will monitor the body infections, in case of chronic and acute bacterial diseases. The design reveals that if blood (serum) comes in contact with fimbriae=pili=BNT embeded immobilised matrix , it will cause IR, designed specifically against the infections of 08: 075: ETEC and 026:EPEC. MRHU (+) strains. These strains were essentially studied to isolate hybrid genetically engineered 5405 MRHU(+) auxotrophic E.coli K-12, non-pathogenic to Balb/c mice, produces at the same time antiadherent immune response to protect mice against fatal 026:EPEC diarrhea. The above results of HA- sero- typing and plasmid profiles supported the concept for the development of bio-materials, and matrix based slow vaccination process.

Keywords

Adherence, Biomaterials, Escherichia Coli K-12, Infecion, MRHU, Plasmid
User

  • Beachy EH (1981) Bacterial Adherence, Adhesin-Receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect. Dis. 143, 325-345.

  • Brahma NK (1999a) Enterobacterial MRHA- Plasmids and its possible genetic transformation with Escherichia coli K-12 at auxotrophic phenotypes. Ind. J. Microbiol. 39, 43-50.

  • Brahma NK (1999b) Genetically Engineered 5405 Hybrid E.coli K-12 fimbrial (pili) vaccination in Balb/c Mice against 026: Serotype EPEC, Diarrhea, J.Ind. Chem. Engg. (ICE); 41, 126.

  • Brahma NK (1996) Application of Enterobacterial plasmids in Genetic Engineering and Hybridoma Techniques. in Innovation technology for the Next Millennium Tata Mc Graw-Hil Pub. Ltd. ND Proceedings of the Indian Engineering Congress, Bangalore, 1996; December, 20-24.

  • Brahma NK (1993) MRHA and Seroprecipitations with 08: ETEC & 026: EPEC surface antigens. Ind.J. of Micribiol.. 33, 233-233.

  • Brahma NK (1998) Design and use of Microbial technology. (Poster) Paper presented in Annual Conference of AMI Association of Microbiologist, held in December in Mangalore, India.

  • Brahma NK (2006) Bio-nanotube of Escherichia coli K-12 and its facilitated transport of biological molecules, AIChE-2006, Spring Conference, Orlando, Florida, USA.

  • Brahma NK (2007) Hybrid blended Polymer of bacterial surface protein (fimbriae= pili= BNT (Bionanotube) as an important Vaccinating and drug delivery Tools: A Biomedical design. Trends in Biomaterials & Artificial Organs. 21, 20-28.

  • Brahma NK Importance of Microbial Genetic Engineering in the Advancement of Biomaterials and Nano-technology, www. Saboi. Org.

  • Brahma, NK (2003) Cell and Tissues in Biomedical Applications, Trends Biomater.Arti.Organs. 17, 17-23.

  • Brahma, NK (2003) The use of Desktop chemical Units in mini and large-scale Plasmids isolations, involved in DNA-cloning. Presented and published in the proceedings of “ Intnl. Conf. on Chem. Bioprocess Engg”, University Malaysia, Sabah. 27-29 August 2003.

  • Braude AI, Devis CF and Frierer (1981) J. Medical Microbiol. Infections Diseases. Saunder Publishers, UK,

  • Brinton CC (1978) In the proceedings of Health Education and the 13th Joint Conference on Cholera (NIH), Deptt. of Health Education Welfares Washington.78,1590.

  • Duguid JP, Smith IW, Dempster G, Edmunds PN. 1955. Non-flagellar filamentous appendages (“fimbriae”) and haemagglutinating activity in Bacterium coli, J. Pathol. Bacteriol. 70, 335.

  • Evans DG, Evans DJ Jr, Clegg S, Pankey JA (1979) Purification and characterisation of the CFA/I Antigen of Enteropathogenic Escherichia Coli . Infect. Immu. 28, 738-748.

  • Evans DJ Jr, Evan DG and Du Pont HL (1979) Haemagglutination patterns of Enteropathogenic and Enterotoxigenic Escheichia coli determined with human. In the presence and absence of mannose. Inf. Immun. 23, 656-657.

  • Hohman A and Wilson MR (1972) Adherence of Escherichia coli to intestinal epitheliums in vivo, Infect. Immun. 12, 866-880.

  • Howick AL and Van Iterson W (1950) Electron microscopical observations on Bacterial cytology II. A study on flagellation. Biochem. Biphys. Acta. 5, 10-44.

  • Isaacson RE (1977) K99 surface antigen of Escheichia coli, Purification and partial characterizations, Infect. Immun. 15, 272-274.

  • ISAMAP2K4 of Material Science Department (2004) IIT –Kharagpur.

  • Kamholz AE, Weigl BH, Finlayson BA and Yager P (1999) Quantitative analysis of molecular interaction in a micro fluidic channel: The T-sensor. Analytical Chemistry. 71, 5340-5347.

  • Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head

  • of bacteriphage T4. Nature (London) 227, 680-685.

  • Marx JL (1980) Vaccinating with bacterial pili. Science 209, 1103-1106.

  • Orskov I (1980) Comparison of E.coli Fimbriae antigen F-7 with type 1 Fimbriae,Infect.Immun. 27, 657-666.

  • Reed JL, Muench KA (1938) simple method of Estimating Fifty percent Endpoints, The American Journal of Hygiene. 27, 493-497.

  • Slait IE and Gotschlich EC (1977) Haemagglutination by purified type 1 Escherichia coli pili., J.Exptl Medicine. 146, 1182-1194.

  • Smith W and Helfer ED (1973) The activity of different Transfer Factors Introduced into the same plasmid containing strain of Escherichia Coli k-12. J. Gen. Microbiol. 78, 89-99.

  • Warburg O and Christian M (1941) Protein Estimation by Ultraviolet adsorption. Biochemie Zeitschrift, Method in Enzymology. 3,451-454.

  • Webers P, Picken R, Schmidt G, Jann B, Jann K, Golecki JR, Manfred K (1980) Characterization of pili associated with Escherichia coli 018: ac. Infec Immun. 29, 680-685.

  • Weigl, BH and Yager P (1999) Microfluidics -Microfluidic diffusion-based separation and detection. Science. 283, 346-347.

  • Zaidi TS, Preston MJ and Pier GB (1997) Inhibition of bacterial adherence to host tissue does not markedly affect disease in the murine model of Pseudomonas aeruginosacorneal infection, nfect. .Immun. 65, 1370–1376.


Abstract Views: 338

PDF Views: 81




  • Understanding of MRHU-plasmids, Bacterial Adherence and Biomaterial in Clinical Application

Abstract Views: 338  |  PDF Views: 81

Authors

Nitosh Kumar Brahma
Department of Chemical Engineering Indian Instiute of Technology, Kharagpur-721302, W.Bengal, India

Abstract


Bacterial adherence has been recently reviewed by plasmid genetic properties of MRHU (D-mannose resistant haemagglutination of human erythrocytes) and change of surface antigens, fimbriae=pili, as an elongated protein appendages to facilitate transport of haemagglutine from cell to bacterial membrane, to lipopolysaccaride (LPS) and to hosts. The fimbriae=pili as expanding elongated protein appendages, have been recently characterised as BNT (Bionanotube) or as ionic channels. The transport of secondary metabolites, haemagglutinine passing through membrane to the external surface, may cause MRHU the colonizations. The mechanisms of MRHU (agglutinating RBC) and their pathogenic activities have been characterised against immune responses (IR) in Balb/C mice. Both the cells and fimbriae showed similar results at different time span. Based on observations, the author designed the concept of one 'Bio-material' to be used for continuous vaccinations and for slow IR, which will monitor the body infections, in case of chronic and acute bacterial diseases. The design reveals that if blood (serum) comes in contact with fimbriae=pili=BNT embeded immobilised matrix , it will cause IR, designed specifically against the infections of 08: 075: ETEC and 026:EPEC. MRHU (+) strains. These strains were essentially studied to isolate hybrid genetically engineered 5405 MRHU(+) auxotrophic E.coli K-12, non-pathogenic to Balb/c mice, produces at the same time antiadherent immune response to protect mice against fatal 026:EPEC diarrhea. The above results of HA- sero- typing and plasmid profiles supported the concept for the development of bio-materials, and matrix based slow vaccination process.

Keywords


Adherence, Biomaterials, Escherichia Coli K-12, Infecion, MRHU, Plasmid

References





DOI: https://doi.org/10.17485/ijst%2F2007%2Fv1i2%2F29202